This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2014 Aug;38(8):862-5.

doi: 10.1016/j.leukres.2014.06.007. Epub 2014 Jun 17.

Orphan drug designation for pracinostat, volasertib and alvocidib in AML

Prithviraj Bose¹, Steven Grant²

Affiliations

Affiliations

¹ Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
² Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA; Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA; Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA; Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: stgrant@vcu.edu.

PMID: 24996975
DOI: 10.1016/j.leukres.2014.06.007

Orphan drug designation for pracinostat, volasertib and alvocidib in AML

Prithviraj Bose et al. Leuk Res. 2014 Aug.

. 2014 Aug;38(8):862-5.

doi: 10.1016/j.leukres.2014.06.007. Epub 2014 Jun 17.

Authors

Prithviraj Bose¹, Steven Grant²

Affiliations

¹ Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
² Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA; Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond, VA, USA; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA; Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA; Institute for Molecular Medicine, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: stgrant@vcu.edu.

PMID: 24996975
DOI: 10.1016/j.leukres.2014.06.007

No abstract available

Keywords: AML; Alvocidib; Flavopiridol; Pracinostat; Rational combinations; Volasertib.

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information